Naloxone shortage could lead to thousands of avoidable overdose deaths

Listen
Text
  • Small
  • Medium
  • Large

A shortage of Pfizer's lifesaving overdose reversal drug naloxone could precipitate a surge in overdose deaths, North Carolina Health News reported Oct. 22.

In August, Pfizer halted production of its single-dose vial version of naloxone because of a manufacturing issue it's been working with the FDA to solve. 

Drug experts estimate the shortage will mean about 1 million fewer naloxone doses, which could lead to as many as 18,000 avoidable overdose deaths.

Pfizer expects the shortage to continue through February, according to the report.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars